The Patent Finder
US

(N-(Cyanomethyl)-4-(2-(4-Morpholinophenylamino)Pyrimidin-4-y l)Benzamide

US RE50,497 In force, term unresolved
OverviewFamilyAssignmentsSources & methods

Term ends no later than Jun 11, 2035 · Low confidence

In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.

Reissue of US 9,469,613, which was surrendered when this reissue was granted; its term and maintenance fees continue here.

Filed Jan 25, 2023 as application 18/159,328 · Granted Jul 22, 2025
Base term, 20 years from filing
Today
20 years from filing
2015 2035
Clock starts
Jun 11, 2015
Ends no later than
Jun 11, 2035
Granted
Jul 22, 2025
base term fee events Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
Unresolved
Terminal disclaimer
On file, reference document not resolved, so the date above is an upper bound. We do not guess the cap.
2 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from the original patent's grant (Oct 18, 2016). This counts the ones the record shows paid.
6
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 2 of 3 maintenance fees are paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jun 11, 2015, when application 14/736,690, the earliest non-provisional in its chain, was filed (this one was filed Jan 25, 2023)Jun 11, 2035High confidence
Continuity chainA reissue: its term follows the original patent's, with the original's term adjustmentfollows the original patentMedium confidence
Patent term adjustmentNo term adjustment record on a grant after 2005, so none is addedno changeMedium confidence
Terminal disclaimer capDisclaimer on file (approved), reference document not resolvedno cap applied, and none guessedMedium confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 3 maintenance fees paidIn forceHigh confidence
Computed term endThe steps above, in orderno later than Jun 11, 2035Low confidence

This family

US 9,469,613Surrendered on reissue
Oct 2020
Oct 2020
US 9,809,559In force
no later than Jun 2035
no later than Jun 2035
US RE48,285In force
Jun 2035
Jun 2035
US RE49,445In force
Jun 2035
Jun 2035
US RE50,497this patent
no later than Jun 2035
no later than Jun 2035
Application 19/245,507Pending
not computed
not computed
The applications whose file history this site holds. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
May 26, 2023
Reel 63777, frame 951
Brown, Brandon H.; Carra, Ernest A.; Hemenway, Jeffrey N.; Morrison, Henry; Reynolds, Troy; Shi, Bing; Stefanidis, Dimitrios; Wang, Fang; Warr, Matthew Robert; Whitney, James Andrew; Xin, YanGilead Sciences, Inc.Assignment of Assignor's Interest
May 26, 2023
Reel 63778, frame 20
Gilead Sciences, Inc.Sierra Oncology, Inc.Assignment of Assignor's Interest
May 26, 2023
Reel 63790, frame 568
Sierra Oncology, Inc.Sierra Oncology LLCChange of Name
Jun 7, 2023
Reel 63879, frame 821
Sierra Oncology LLCGlaxoSmithKline LLCAssignment of Assignor's Interest
Jun 17, 2025
Reel 71428, frame 694
Brown, Brandon H.; Carra, Ernest A.; Hemenway, Jeffrey N.; Morrison, Henry; Reynolds, Troy; Shi, Bing; Stefanidis, Dimitrios; Wang, Fang; Warr, Matthew Robert; Whitney, James Andrew; Xin, YanGilead Sciences, Inc.Assignment of Assignor's Interest
Jun 17, 2025
Reel 71428, frame 809
Gilead Sciences, Inc.Sierra Oncology, Inc.Assignment of Assignor's Interest
Jun 17, 2025
Reel 71428, frame 961
Sierra Oncology LLCGlaxoSmithKline LLCAssignment of Assignor's Interest
Jun 17, 2025
Reel 71656, frame 380
Sierra Oncology, Inc.Sierra Oncology LLCChange of Name

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited